Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


27.06.2022

3 Ann Rheum Dis
2 Arthritis Res Ther
2 Clin Rheumatol
1 Intern Med
2 PLoS One
1 Rheumatol Int
1 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. KERSCHBAUMER A, Rivai ZI, Smolen JS, Aletaha D, et al
    Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis.
    Ann Rheum Dis. 2022 Jun 20. pii: annrheumdis-2021-221807.
    PubMed         Abstract available

  2. NEMETH T, Nagy G, Pap T
    Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
    Ann Rheum Dis. 2022 Jun 17. pii: annrheumdis-2021-222021.
    PubMed         Abstract available

  3. LAUPER K, Ludici M, Mongin D, Bergstra SA, et al
    Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
    Ann Rheum Dis. 2022 Jun 15. pii: annrheumdis-2022-222586.
    PubMed         Abstract available


    Arthritis Res Ther

  4. ELISA G, Tolusso B, Petricca L, Di Mario C, et al
    Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig.
    Arthritis Res Ther. 2022;24:143.
    PubMed         Abstract available

  5. SAKELLARIOU G, Scire CA, Rumi F, Carrara G, et al
    Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases.
    Arthritis Res Ther. 2022;24:144.
    PubMed         Abstract available


    Clin Rheumatol

  6. MEHTA P, Redhead G, Nair A, Sparks JA, et al
    Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?
    Clin Rheumatol. 2022 Jun 22. pii: 10.1007/s10067-022-06245.
    PubMed        

  7. BOZZALLA CASSIONE E, Mansoubi M, Mazzucchelli I, Luvaro T, et al
    No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission.
    Clin Rheumatol. 2022 Jun 22. pii: 10.1007/s10067-022-06250.
    PubMed        


    Intern Med

  8. YASUI S, Yoshida A, Takata M, Kamitani Y, et al
    Rheumatoid Arthritis Symptoms Diagnosed by Rheumatic Immune-related Adverse Events Caused by Nivolumab in a Patient with Esophageal Cancer: A Case Report.
    Intern Med. 2022 Jun 21. doi: 10.2169/internalmedicine.9663.
    PubMed         Abstract available


    PLoS One

  9. MORI S, Okada A, Koga T, Ueki Y, et al
    Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.
    PLoS One. 2022;17:e0270391.
    PubMed         Abstract available

  10. MIKAMI S, Miura Y, Kondo S, Sakai K, et al
    Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice.
    PLoS One. 2022;17:e0270056.
    PubMed         Abstract available


    Rheumatol Int

  11. HAN P, Sun C, Zhang Y, Yan J, et al
    Sjogren's syndrome with adult-onset Still's disease: an overlap syndrome?
    Rheumatol Int. 2022;42:1281-1285.
    PubMed         Abstract available


    Z Rheumatol

  12. MISCHKEWITZ M, Alten R
    [This is how we treat rheumatoid nodules in patients with rheumatoid arthritis in remission].
    Z Rheumatol. 2022 Jun 20. pii: 10.1007/s00393-022-01228.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: